Ahead Study News Today

Research shows African Americans being twice as likely than their white counterparts to develop brain diseases, according to an expert.

Two North Carolina universities are conducting clinical trials involving a Food and Drug Administration-approved drug for Alzheimer’s.

Both Wake Forest and Duke University are holding the trails.

SEQUENCE, a Phase 3 head-to-head study, compared risankizumab to ustekinumab for the treatment of adult patients with moderately to severely active Crohns...

Why do I keep getting stomach issues during heat waves?

According to studies required by the FDA, it helps to reduce amyloid plaques in the brain protein and has a functional benefit in patients.

This new phase 4 data provides some valuable insights for healthcare professionals and those seeking to compare therapy options for psoriasis.

Neurologist explains why recent trial of the drug lecanemab may offer hope for those with deadly disease.

Artists come together to create art during an evening of fun and fundraising to support young artists

Auctions can be wildly unpredictable. Bidders fight to the death over something that was not the main attraction, while the latter goes largely ignored.